Revici's Guided Chemotherapy

Revici's Guided Chemotherapy is an ineffective cancer treatment devised by Emanuel Revici (1896–1997).[1]

Revici's early work on experimental chemical-based treatments for cancer between 1920–1941 attracted a degree of support. However his work increasingly found disfavor with the scientific and medical communities and his license was revoked in 1993.[1]

Revici's Guided Chemotherapy is based on the idea that all illness is caused by an "imbalance" of metabolism.[2] The treatment is to give a mixture of chemical substances (usually including lipid alcohol and various metals) by mouth or injection. A Clinical Appraisal Group was organized in January 1963 to evaluate Revici's cancer treatment. The group concluded that the treatment has no value.[3] The American Cancer Society notes that Revici's Guided "chemotherapy" is different from modern conventional chemotherapy, and states: "Available scientific evidence does not support claims that Revici's guided chemotherapy is effective in treating cancer or any other disease. It may also cause potentially serious side effects."[4]

See also
  • List of ineffective cancer treatments

References
  1. Cohen, MA (1998). "Emanuel Revici, M.D.: Innovator in nontoxic cancer chemotherapy 1896-1997". Journal of Alternative and Complementary Medicine. 4 (2): 140–5. doi:10.1089/acm.1998.4.137. PMID 9628204.
  2. Vickers, A. (2004). "Alternative Cancer Cures: "Unproven" or "Disproven"?". CA: A Cancer Journal for Clinicians. 54 (2): 110–8. CiteSeerX 10.1.1.521.2180. doi:10.3322/canjclin.54.2.110. PMID 15061600.
  3. Lyall, David (1965). "Treatment of Cancer by the Method of Revici". JAMA: The Journal of the American Medical Association. 194 (3): 279. doi:10.1001/jama.1965.03090160057014.
  4. "Complementary and Alternative Medicine". American Cancer Society. Retrieved 9 August 2018.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.